Quick answers
- What is Hyrimoz?
- Hyrimoz is a brand name of Adalimumab-atto, a prescription medicine. The FDA NDC Directory lists 11 Hyrimoz products in 5 strengths and forms.
- Who makes Hyrimoz?
- Sandoz Inc holds the FDA application for Hyrimoz (BLA761071, approved October 30, 2018). 1 other company (repackagers or distributors) also list Hyrimoz products.
- Is there a generic or store brand of Hyrimoz?
- Yes. The FDA NDC Directory lists 10 other products with the same active ingredients, strength and form as a Hyrimoz product. Ask your pharmacist whether one is right for you.
- Has Hyrimoz been recalled?
- No recall linked to Hyrimoz products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Hyrimoz is
Each Hyrimoz product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Adalimumab-atto · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| adalimumab 10 mg/0.1 mL injection, solution (subcutaneous) | Hyrimoz | 1 product, 1 company | DailyMed |
| adalimumab 20 mg/0.2 mL injection, solution (subcutaneous) | Hyrimoz | 1 product, 1 company | DailyMed |
| adalimumab 40 mg/0.4 mL injection, solution (subcutaneous) | Hyrimoz | 2 products, 2 companies | DailyMed |
| adalimumab 40 mg/0.8 mL injection, solution (subcutaneous) | Hyrimoz | 4 products, 2 companies | DailyMed |
| adalimumab 80 mg/0.8 mL injection, solution (subcutaneous) | Hyrimoz | 2 products, 2 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Adalimumab-atto →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761071 | Sandoz Inc | October 30, 2018 | 11 |
Companies that list Hyrimoz
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Hyrimoz products.
- Cordavis Limited7 products
- Sandoz Inc4 products
Recalls
No recall linked to Hyrimoz products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.